The Unlikely Pioneer Behind mRNA Vaccines

Christa Pike survived two doses of a lethal injection drug last week during a botched execution in Tennessee.Pamela Colloff, who writes for The New York Times Magazine, discusses the waning public support for the death penalty and why despite it some states are doubling down.Gues ...  Show more

What exactly happened near an air base in Britain used by the United States?Eric Schmitt, a national security correspondent for The New York Times, discusses what he’s learned about the mysterious events around the base, including the abrupt withdrawal of U.S. Air Force bombers.G ...  Show more

The founders of German biotechnology company BioNTech were researching how to fight cancers using messenger RNA, "the unloved cousin of DNA", when covid-19 first appeared and they realised mRNA could be used to make a vaccine for the disease. Financial Times journalist Joe Miller ...  Show more

The COVID-19 vaccine came out at warp speed because of the work of these two scientists.  For many years they had been investigating the secrets of messenger RNA (mRNA).  And when the pandemic began, their research was ready and waiting. On this episode you’ll hear Katalin Kar ...

Kizzmekia Corbett is a 34-year-old viral immunologist, and she might help save the world. She leads the coronavirus vaccine research at the National Institutes of Health, and the mRNA vaccine they’ve developed in collaboration with Moderna has reported an astounding 94.5% efficac ...  Show more

How do you fight a pandemic? With cutting edge technology. Two of the new Covid-19 vaccines applying for FDA approval rely on a novel approach that uses mRNA to turn the human body into an internal vaccine factory. CNN Chief Medical Correspondent Dr. Sanjay Gupta talks to mRNA re ...  Show more